Declared Dividend • 4h
Fourth quarter dividend of US$0.69 announced Shareholders will receive a dividend of US$0.69. Ex-date: 4th September 2026 Payment date: 25th September 2026 Dividend yield will be 0.6%, which is lower than the industry average of 3.1%. Payout Ratios Payout ratio: 31%. Cash payout ratio: 25%. Announcement • Jan 29
STERIS plc Announces Quarterly Dividend, Payable on March 19, 2026 STERIS plc announced that the company will distribute a quarterly dividend of $0.63 per share. The dividend is payable on March 19, 2026, to shareholders of record at the close of business on February 17, 2026. Announcement • Jan 22
STERIS plc to Report Q3, 2026 Results on Feb 04, 2026 STERIS plc announced that they will report Q3, 2026 results After-Market on Feb 04, 2026 Announcement • Nov 06
STERIS plc Maintains Earnings Guidance for Fiscal Year 2026 STERIS plc maintained earnings guidance for fiscal year 2026. For fiscal 2026, the Company expects as reported revenue from continuing operations to increase 8-9%, unchanged from prior outlook. Announcement • Oct 30
STERIS plc Declares Quarterly Dividend, Payable on December 18, 2025 STERIS plc announced that the Company will distribute a quarterly dividend of $0.63 per share. The dividend is payable on December 18, 2025, to shareholders of record at the close of business on November 18, 2025. Announcement • Oct 22
STERIS plc to Report Q2, 2026 Results on Nov 05, 2025 STERIS plc announced that they will report Q2, 2026 results After-Market on Nov 05, 2025 Announcement • Jul 31
Steris plc Declares Quarterly Interim Dividend, Payable on September 26, 2025 STERIS plc announced that it will distribute a quarterly interim dividend of $0.63 per share. This represents a $0.06 increase in the dividend and the Company’s 20th consecutive year of dividend growth. The dividend is payable on September 26, 2025, to shareholders of record at the close of business on September 4, 2025. Announcement • Jul 23
STERIS plc to Report Q1, 2026 Results on Aug 06, 2025 STERIS plc announced that they will report Q1, 2026 results After-Market on Aug 06, 2025 Announcement • Jul 04
STERIS plc Announces Retirement of Richard Steeves as Director, Effective from July 31, 2025 On July 1, 2025, Dr. Richard Steeves notified STERIS plc (the “Company”) that he will retire from the Board of Directors (the “Board”) on the date of the Company’s Annual General Meeting of Shareholders (the “Annual Meeting”) to be held on July 31, 2025. Therefore, Dr. Steeves will not stand for re-election to the Board at the Annual Meeting. Dr. Steeves’ decision to retire is not the result of any disagreement with the Company on any matters related to the Company’s strategy, operations, policies or practices. The Company and the Board thank Dr. Steeves for his 10 years of service to the Company as a Director. Announcement • Jun 30
STERIS plc(NYSE:STE) dropped from Russell 1000 Dynamic Index STERIS plc(NYSE:STE) dropped from Russell 1000 Dynamic Index Announcement • Jun 13
STERIS plc, Annual General Meeting, Jul 31, 2025 STERIS plc, Annual General Meeting, Jul 31, 2025. Location: 70 sir john rogerson s quay dublin 2, d02 r296 ireland, dublin Ireland Announcement • May 15
STERIS plc Provides Earnings Guidance for the Fiscal Year 2026 STERIS plc provided earnings guidance for the fiscal year 2026. For the year, the company expects revenue from continuing operations to increase 6% -7%. Based on forward rates through March 31, 2026, currency is expected to be neutral to revenue in fiscal 2026. As a result, constant currency organic revenue growth from continuing operations is also anticipated to be 6% -7%. Announcement • May 08
STERIS plc Declares Quarterly Interim Dividend, Payable on June 26, 2025 STERIS plc announced that the company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on June 26, 2025, to shareholders of record at the close of business on June 10, 2025. Announcement • Apr 23
STERIS plc to Report Q4, 2025 Results on May 14, 2025 STERIS plc announced that they will report Q4, 2025 results After-Market on May 14, 2025 Announcement • Feb 06
STERIS plc Updates Earnings Guidance for the Fiscal Year 2025 STERIS plc updated earnings guidance for the fiscal year 2025. For the period, company expects reported revenue to increase approximately 6% compared with prior expectations of 6.5% to 7.5%. This change is primarily due to currency, as forward rates through March 31, 2025, are now expected to be unfavorable to revenue in fiscal 2025, as well as lower than anticipated revenue for capital equipment in the Healthcare segment. Constant currency organic revenue from continuing operations is also now anticipated to be approximately 6%, compared with prior expectations of 6% to 7%. Announcement • Jan 23
STERIS plc to Report Q3, 2025 Results on Feb 05, 2025 STERIS plc announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Feb 05, 2025 Announcement • Nov 07
STERIS plc Reiterates Financial Guidance for the Fiscal Year 2025 STERIS plc reiterated financial guidance for the fiscal year 2025. For fiscal 2025, the Company continues to expect as reported revenue to increase 6.5% to 7.5%. Based on forward rates through March 31, 2025, currency is expected to be slightly favorable to revenue in fiscal 2025. Constant currency organic revenue from continuing operations is anticipated to increase 6% to 7%. Announcement • Oct 31
STERIS plc Declares Distribute A Quarterly Interim Dividend, Payable on December 19, 2024 STERIS plc announced that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on December 19, 2024, to shareholders of record at the close of business on November 19, 2024. Announcement • Oct 24
STERIS plc to Report Q2, 2025 Results on Nov 06, 2024 STERIS plc announced that they will report Q2, 2025 results After-Market on Nov 06, 2024 Announcement • Aug 07
STERIS plc Provides Earnings Guidance for the Year 2025 STERIS plc provided earnings guidance for the year 2025. For fiscal 2025, the Company continues to expect as reported revenue from continuing operations to increase 6.5%-7.5%. Constant currency organic revenue from continuing operations is anticipated to increase 6%-7%. Total annual revenue for this business in fiscal 2024 was approximately $35 million which will be excluded from constant currency organic revenue growth from continuing operations in fiscal 2025. Announcement • Aug 01
STERIS plc Raises Quarterly Interim Dividend, Payable on September 20, 2024 STERIS plc announced that the Company will distribute a quarterly interim dividend of $0.57 per share. This represents a $0.05 increase in the dividend and the Company’s 19th consecutive year of dividend growth. The dividend is payable on September 20, 2024, to shareholders of record at the close of business on September 5, 2024. Announcement • Jul 24
STERIS plc to Report Q1, 2025 Results on Aug 06, 2024 STERIS plc announced that they will report Q1, 2025 results After-Market on Aug 06, 2024 Announcement • Jun 15
STERIS plc, Annual General Meeting, Aug 01, 2024 STERIS plc, Annual General Meeting, Aug 01, 2024. Location: 70 sir john rogersons, quay, dublin Ireland Announcement • May 10
STERIS plc Provides Earnings Guidance for the Fiscal Year 2025 STERIS plc provided earnings guidance for the fiscal year 2025. For fiscal 2025, the company expects as reported revenue from continuing operations to increase 6.5% to 7.5%. Based on forward rates through March 31, 2025, currency is expected to be neutral to revenue in fiscal 2025. Constant currency organic revenue from continuing operations is anticipated to increase 6% to 7%. Announcement • May 02
STERIS plc Announces Quarterly Interim Dividend, Payable on June 26, 2024 STERIS plc announced that the company will distribute a quarterly interim dividend of $0.52 per share. The dividend is payable on June 26, 2024, to shareholders of record at the close of business on June 12, 2024. Announcement • Apr 26
STERIS plc to Report Q4, 2024 Results on May 08, 2024 STERIS plc announced that they will report Q4, 2024 results After-Market on May 08, 2024 Announcement • Feb 08
STERIS plc Revises Financial Guidance for the Fiscal Year 2024 STERIS plc revised financial guidance for the fiscal year 2024. For fiscal 2024, the Company now expects as reported revenue to increase 10-11%, an increase from previous expectations of 9-10%. Expectations for constant currency organic revenue growth are also increased to 7-8% from prior expectations of 6-7%. Announcement • Jan 31
STERIS plc Announces Quarterly Interim Dividend, Payable on March 22, 2024 STERIS plc announced that the Company will distribute a quarterly interim dividend of $0.52 per share. The dividend is payable on March 22, 2024, to shareholders of record at the close of business on February 23, 2024. Announcement • Jan 24
STERIS plc to Report Q3, 2024 Results on Feb 07, 2024 STERIS plc announced that they will report Q3, 2024 results After-Market on Feb 07, 2024 Announcement • Nov 10
STERIS plc Confirms Earnings Guidance for the Fiscal Year 2024 STERIS plc confirmed earnings guidance for the fiscal year 2024. For the year the company expected revenue growth of 9% to 10% and constant currency organic revenue growth of 6% to 7%. Announcement • Nov 01
STERIS plc Announces Quarterly Interim Dividend, Payable on December 21, 2023 STERIS plc announced that the Company will distribute a quarterly interim dividend of $0.52 per share. The dividend is payable on December 21, 2023, to shareholders of record at the close of business on November 21, 2023. Announcement • Oct 25
STERIS plc to Report Q2, 2024 Results on Nov 07, 2023 STERIS plc announced that they will report Q2, 2024 results at 4:00 PM, US Eastern Standard Time on Nov 07, 2023 Announcement • Jul 29
STERIS plc Appoints Dr. Esther Alegria to Serve on the Compliance and Technology Committee and the Nominating and Governance Committee of the Board STERIS plc announced on July 27, 2023, Dr. Esther Alegria was appointed to serve on the Compliance and Technology Committee and the Nominating and Governance Committee of the Board. Announcement • Jul 22
STERIS plc to Report Q1, 2024 Results on Aug 01, 2023 STERIS plc announced that they will report Q1, 2024 results on Aug 01, 2023 Announcement • Jun 09
STERIS plc, Annual General Meeting, Jul 27, 2023 STERIS plc, Annual General Meeting, Jul 27, 2023, at 04:00 Eastern Daylight. Location: 70 Sir John Rogerson's Quay Dublin 2, Ireland Dublin 2 Ireland Agenda: To consider ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending For March 31, 2024; to appoint Ernst & Young Chartered Accountants as the Company's statutory auditor under Irish law to hold office until the For conclusion of the Company's next annual general meeting' to authorize the Board of Directors of the Company or the Audit Committee of the Board of Directors to determine the remuneration of For Ernst & Young Chartered Accountants as the Company's statutory auditor under Irish law; to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the U.S. Securities and Exchange Commission, including the compensation discussion and analysis and the tabular and For narrative disclosure contained in the Company's proxy statement dated June 7, 2023; and to consider other matters if any. Announcement • May 12
STERIS plc Provides Revenue Guidance for the Fiscal Year 2024 STERIS plc provided revenue guidance for the fiscal year 2024. For fiscal 2024, as reported revenue is expected to increase 7-8%, reflecting the anticipated positive impact of foreign currency fluctuations based on forward rates through March 31, 2024. Constant currency organic revenue growth is anticipated to increase 6-7%. Recent Insider Transactions • Mar 08
Insider recently sold Mex$3.9m worth of stock On the 3rd of March, Cary Majors sold around 1k shares on-market at roughly Mex$3,426 per share. This transaction amounted to 9.2% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of Mex$9.8m more than they bought in the last 12 months. Upcoming Dividend • Feb 16
Upcoming dividend of US$0.47 per share at 0.9% yield Eligible shareholders must have bought the stock before 23 February 2023. Payment date: 23 March 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 0.9%. Lower than top quartile of Mexican dividend payers (5.7%). Lower than average of industry peers (1.7%). Reported Earnings • Feb 09
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: US$1.22b (flat on 3Q 2022). Net income: US$123.8m (down 14% from 3Q 2022). Profit margin: 10% (down from 12% in 3Q 2022). Revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 8.6% growth forecast for the Global Medical Equipment industry. Announcement • Feb 09
STERIS plc Updates Financial Guidance for the Fiscal Year Ending March 31, 2023 STERIS plc updated financial guidance for the fiscal year ending March 31, 2023. As reported revenue is now anticipated to grow 6% compared with prior expectations of 8% growth. Based on foreign currency forward rates through March 31, 2023, currency is now anticipated to negatively impact revenue by approximately $110 million this fiscal year, a reduction from prior expectations of approximately $150 million. Constant currency organic revenue is now anticipated to grow approximately 7% compared with prior expectations of 10%. Announcement • Feb 02
STERIS plc Declares Quarterly Interim Dividend, Payable on March 23, 2023 STERIS plc announced that the Company will distribute a quarterly interim dividend of $0.47 per share. The dividend is payable March 23, 2023 to shareholders of record at the close of business on February 24, 2023. Announcement • Jan 26
STERIS plc to Report Q3, 2023 Results on Feb 08, 2023 STERIS plc announced that they will report Q3, 2023 results After-Market on Feb 08, 2023 Recent Insider Transactions • Dec 07
Insider recently sold Mex$5.9m worth of stock On the 1st of December, Cary Majors sold around 2k shares on-market at roughly Mex$3,687 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Upcoming Dividend • Nov 17
Upcoming dividend of US$0.47 per share Eligible shareholders must have bought the stock before 21 November 2022. Payment date: 16 December 2022. The company is not currently making a profit but it is cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Mexican dividend payers (6.7%). Lower than average of industry peers (1.7%). Reported Earnings • Nov 11
Second quarter 2023 earnings released Second quarter 2023 results: Revenue: US$1.20b (flat on 2Q 2022). Net loss: US$315.3m (down US$385.1m from profit in 2Q 2022). Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 9.2% growth forecast for the Global Medical Equipment industry. Upcoming Dividend • Aug 30
Upcoming dividend of US$0.47 per share Eligible shareholders must have bought the stock before 06 September 2022. Payment date: 23 September 2022. Payout ratio is a comfortable 46% and this is well supported by cash flows. Trailing yield: 0.9%. Lower than top quartile of Mexican dividend payers (6.2%). Lower than average of industry peers (1.7%). Reported Earnings • Aug 03
First quarter 2023 earnings released: EPS: US$1.11 (vs US$0.24 loss in 1Q 2022) First quarter 2023 results: EPS: US$1.11 (up from US$0.24 loss in 1Q 2022). Revenue: US$1.16b (up 19% from 1Q 2022). Net income: US$111.3m (up US$133.1m from 1Q 2022). Profit margin: 9.6% (up from net loss in 1Q 2022). Over the next year, revenue is forecast to grow 9.3%, compared to a 19% growth forecast for the industry in Mexico. Upcoming Dividend • Jun 06
Upcoming dividend of US$0.43 per share Eligible shareholders must have bought the stock before 13 June 2022. Payment date: 28 June 2022. Payout ratio is a comfortable 68% and this is well supported by cash flows. Trailing yield: 0.8%. Lower than top quartile of Mexican dividend payers (5.9%). Lower than average of industry peers (1.6%). Reported Earnings • Jun 01
Full year 2022 earnings released: EPS: US$2.50 (vs US$4.66 in FY 2021) Full year 2022 results: EPS: US$2.50 (down from US$4.66 in FY 2021). Revenue: US$4.59b (up 48% from FY 2021). Net income: US$243.9m (down 39% from FY 2021). Profit margin: 5.3% (down from 13% in FY 2021). Over the next year, revenue is forecast to grow 12%, compared to a 17% growth forecast for the industry in Mexico. 
